Mortality trends for multiple sclerosis patients in Sweden from 1968 to 2012

Sarah Burkill1, Scott Montgomery2, MohammadHossein Hajiebrahimi2

  • 1From the Clinical Epidemiology Unit (S.B., S.M., M.H., S.B) and Centre for Pharmacoepidemiology (S.B., S.B.), Department of Medicine, Solna, Karolinska Institutet, Stockholm; Clinical Epidemiology and Biostatistics (S.M.), School of Medical Sciences, Örebro University, Sweden; Department of Epidemiology and Public Health (S.M.), University College London, UK; Division of Neurology (J.H.) and Neuroimmunology Unit (T.O.), Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden; and Biostatistics and Epidemiology Unit (M.H., S.B.), Health Faculty, Golestan University of Medical Sciences, Golestan, Iran. Sarah.Burkill@ki.se.

Neurology
|July 9, 2017
PubMed
Abstract

Insights

Mortality for multiple sclerosis (MS) patients significantly decreased over time, showing substantial improvements in survival rates. However, individuals with MS still face higher mortality risks compared to the general population.

Area of Science:

  • Neurology
  • Epidemiology
  • Public Health

Background:

  • Multiple sclerosis (MS) is a chronic neurological disease with significant impact on patient mortality.
  • Understanding mortality trends in MS is crucial for improving patient care and public health strategies.

Purpose of the Study:

  • To analyze mortality trends and causes of death in patients with multiple sclerosis (MS) in Sweden.
  • To compare mortality rates between individuals with MS and matched controls without MS.

Main Methods:

  • A Swedish cohort study identified 29,617 patients with MS (1964-2012) and matched them with 296,164 controls.
  • Cox proportional hazard models were used to assess mortality risk in the MS cohort.
  • Data on causes of death were obtained from the Causes of Death Register.

Main Results:

  • Patients with MS had a 2.92-fold increased risk of all-cause mortality compared to controls.
  • Respiratory and infectious diseases showed the largest mortality differences (HR 5.07 and 4.07, respectively).
  • Mortality risk for MS patients significantly decreased over time, with hazard ratios reducing from 6.52 (1968-1980) to 2.08 (2001-2012).

Conclusions:

  • Substantial improvements in survival have been observed for patients with MS, with significant reductions in mortality across various causes.
  • Despite these improvements, individuals with MS continue to experience higher mortality rates than the general population.
  • Further research and interventions are needed to address the remaining mortality disparities.

Related Concept Videos

Longitudinal Research02:20

Longitudinal Research

Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
13.5K
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
335
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
797
Life Tables01:22

Life Tables

A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...
573
Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
779
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
462